Commentary on Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer: Yuen JS, Akkaya E, Wang Y, Takiguchi M, Peak S, Sullivan M, Protheroe AS, Macaulay VM, Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Headington, Oxford, United Kingdom

✍ Scribed by Joel W. Slaton

• Book ID: 116956622
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 83 KB
• Volume: 27
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2009.07.031